Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
Purpose of the study is to determine midazolam's safety and dose-linearity when delivered
intramuscularly via an autoinjector. The proposed initial treatment dosage for seizures
induced by exposure to nerve agents.